Arnab Ray

1.4k total citations
24 papers, 549 citations indexed

About

Arnab Ray is a scholar working on Infectious Diseases, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Arnab Ray has authored 24 papers receiving a total of 549 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 7 papers in Molecular Biology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Arnab Ray's work include Clostridium difficile and Clostridium perfringens research (8 papers), Microscopic Colitis (7 papers) and Gut microbiota and health (5 papers). Arnab Ray is often cited by papers focused on Clostridium difficile and Clostridium perfringens research (8 papers), Microscopic Colitis (7 papers) and Gut microbiota and health (5 papers). Arnab Ray collaborates with scholars based in United States, India and France. Arnab Ray's co-authors include Robert B. Smith, Kathleen M. Mullane, Robert Orenstein, Mayur Ramesh, Erik R. Dubberke, Darrell S. Pardi, Robert Hardi, Lawrence J. Brandt, Christina M. Surawicz and Colleen Kelly and has published in prestigious journals such as Gastroenterology, Clinical Infectious Diseases and European Heart Journal.

In The Last Decade

Arnab Ray

22 papers receiving 537 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Arnab Ray United States 10 388 285 183 155 118 24 549
Monika Widłak United Kingdom 7 364 0.9× 208 0.7× 273 1.5× 188 1.2× 186 1.6× 17 669
Yao‐Wen Cheng United States 11 252 0.6× 193 0.7× 122 0.7× 132 0.9× 148 1.3× 26 459
Mustafa Alani United States 6 370 1.0× 261 0.9× 240 1.3× 163 1.1× 153 1.3× 19 563
Juan Antonio Casellas Spain 15 84 0.2× 425 1.5× 121 0.7× 71 0.5× 495 4.2× 42 1.1k
Tae‐Geun Gweon South Korea 14 112 0.3× 109 0.4× 56 0.3× 123 0.8× 178 1.5× 53 429
W Knapple United States 9 195 0.5× 134 0.5× 94 0.5× 125 0.8× 311 2.6× 25 569
Holger Schäffler Germany 13 167 0.4× 171 0.6× 218 1.2× 51 0.3× 81 0.7× 25 517
Robert Keskey United States 12 92 0.2× 106 0.4× 221 1.2× 24 0.2× 158 1.3× 27 515
Željko Puljiz Croatia 12 39 0.1× 154 0.5× 83 0.5× 58 0.4× 130 1.1× 34 473
Claudia Simonelli Italy 5 284 0.7× 202 0.7× 161 0.9× 100 0.6× 88 0.7× 9 430

Countries citing papers authored by Arnab Ray

Since Specialization
Citations

This map shows the geographic impact of Arnab Ray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arnab Ray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arnab Ray more than expected).

Fields of papers citing papers by Arnab Ray

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arnab Ray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arnab Ray. The network helps show where Arnab Ray may publish in the future.

Co-authorship network of co-authors of Arnab Ray

This figure shows the co-authorship network connecting the top 25 collaborators of Arnab Ray. A scholar is included among the top collaborators of Arnab Ray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arnab Ray. Arnab Ray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fischer, Monika & Arnab Ray. (2023). Future Microbiome Therapeutics for Clostridioides difficile Infection. The American Journal of Gastroenterology. 119(1S). S27–S29. 3 indexed citations
2.
Shen, Yuanjun, Dmitry A. Goncharov, Andressa Peña, et al.. (2022). Cross-talk between TSC2 and the extracellular matrix controls pulmonary vascular proliferation and pulmonary hypertension. Science Signaling. 15(763). eabn2743–eabn2743. 14 indexed citations
4.
Shen, Yuanjun, Dmitry A. Goncharov, Arnab Ray, et al.. (2020). Differential effects of integrin‐linked kinase inhibitor Cpd22 on severe pulmonary hypertension in male and female rats. Pulmonary Circulation. 10(1). 1–12. 10 indexed citations
5.
Ray, Arnab, et al.. (2020). S1766 Ocrelizumab-Induced Colitis: A Case Report. The American Journal of Gastroenterology. 115(1). S913–S913. 8 indexed citations
6.
Mubarak, Muhammed, et al.. (2018). Metastatic Renal Cell Carcinoma Presenting as a Bleeding Gastric Polyp. Ochsner Journal. 18(3). 274–276. 3 indexed citations
7.
Peña, Andressa, Ahasanul Kobir, Dmitry A. Goncharov, et al.. (2017). Pharmacological Inhibition of mTOR Kinase Reverses Right Ventricle Remodeling and Improves Right Ventricle Structure and Function in Rats. American Journal of Respiratory Cell and Molecular Biology. 57(5). 615–625. 36 indexed citations
8.
Mubarak, Muhammed, et al.. (2017). Metastatic Renal Cell Carcinoma Presenting as a Bleeding Gastric Polyp. The American Journal of Gastroenterology. 112. S1042–S1043.
9.
Ray, Arnab, et al.. (2017). Sclerosing Mesentritis Followed by Pleurisy: A Rare Presentation. Gastroenterology. 152(5). S1266–S1266.
10.
Ray, Arnab, et al.. (2016). Does the Donor Matter? Results from PUNCH CD 2: A Randomized Controlled Trial of a Microbiota-based Drug for Recurrent Clostridium difficile Infection. The American Journal of Gastroenterology. 111. S65–S66. 1 indexed citations
12.
Orenstein, Robert, Erik R. Dubberke, Robert Hardi, et al.. (2015). Safety and Durability of RBX2660 (Microbiota Suspension) for RecurrentClostridium difficileInfection: Results of the PUNCH CD Study. Clinical Infectious Diseases. 62(5). 596–602. 161 indexed citations
13.
Aroniadis, Olga C., Lawrence J. Brandt, Adam Eric Greenberg, et al.. (2015). Long-term Follow-up Study of Fecal Microbiota Transplantation for Severe and/or Complicated Clostridium difficile Infection. Journal of Clinical Gastroenterology. 50(5). 398–402. 78 indexed citations
14.
Agrawal, Manasi, Olga C. Aroniadis, Lawrence J. Brandt, et al.. (2015). The Long-term Efficacy and Safety of Fecal Microbiota Transplant for Recurrent, Severe, and Complicated Clostridium difficile Infection in 146 Elderly Individuals. Journal of Clinical Gastroenterology. 50(5). 403–407. 142 indexed citations
15.
Pareek, Anil, Nitin Chandurkar, Nithya Gogtay, et al.. (2015). Sustained Release Formulation of Primaquine for Prevention of Relapse of Plasmodium vivax Malaria: A Randomized, Double-Blind, Comparative, Multicentric Study. Europe PMC (PubMed Central). 2015. 1–8. 5 indexed citations
16.
Ray, Arnab, et al.. (2014). Fecal Microbiota Transplantation for Clostridium difficile Infection: The Ochsner Experience.. PubMed. 14(4). 538–44. 22 indexed citations
17.
18.
Ray, Arnab, Tatsuki Koyama, Alan J. Herline, et al.. (2005). Crohnʼs Perianal Fistulas and the Incidence of Fecal Incontinence. The American Journal of Gastroenterology. 100. S294–S294. 1 indexed citations
19.
Patterson, Richard J., et al.. (1995). Hypersensitivity pneumonitis in a raptor handler and a wild bird fancier.. PubMed. 74(5). 437–41. 13 indexed citations
20.
Ray, Arnab, et al.. (1987). Protein and 28S ribosomal RNA fractional turnover rates in the rat heart after abdominal aortic stenosis. Cardiovascular Research. 21(8). 587–592. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026